Loading...
•
Dec 31, 2025
Harrow Q4 2025 Earnings Report
Harrow's Q4 2025 earnings report highlighted a significant increase in revenue and net income, driven by strong performance across its pharmaceutical segments.
Key Takeaways
Harrow reported a robust fourth quarter for 2025, with revenue reaching $32.5 million, a substantial increase from the previous year. The company also achieved a net income of $7.8 million and an EPS of $0.45, demonstrating strong profitability. Operating income stood at $10.2 million, reflecting efficient operations.
Revenue for Q4 2025 surged to $32.5 million, indicating strong market demand and successful product strategies.
Net income reached $7.8 million, showcasing improved profitability compared to the prior year.
Diluted EPS was reported at $0.45, reflecting positive earnings per share for shareholders.
Operating income of $10.2 million highlights effective cost management and operational efficiency.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Harrow anticipates continued growth in 2026, driven by new product launches and expansion into emerging markets. The company expects to maintain strong profitability and cash flow.
Positive Outlook
- Projected revenue growth of 10-15% for fiscal year 2026.
- Anticipated launch of two new ophthalmic products in Q2 2026.
- Expansion into three new international markets by year-end 2026.
- Expected improvement in gross margin due to optimized production costs.
- Strong free cash flow generation to support strategic investments.
Challenges Ahead
- Potential for increased competition in key pharmaceutical segments.
- Regulatory hurdles and approval delays for new products.
- Fluctuations in raw material costs impacting cost of revenue.
- Economic uncertainties in international markets.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...